The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.
Abstract
We studied the effects of different classes of inotropic drugs on human working myocardium in vitro that was isolated from the hearts of patients with end-stage heart failure, and compared the responses to these drugs with those noted in muscles from nonfailing control hearts. Although peak isometric force generated in response to increased extracellular calcium reached control levels in the muscles from patients with heart failure, the time course of contraction and rate of relaxation were greatly prolonged. The inotropic effectiveness of the beta-adrenergic agonist isoproterenol and the phosphodiesterase inhibitors milrinone, caffeine, and isobutylmethylxanthine was markedly reduced in muscles from the patients with heart failure. In contrast, the effectiveness of inotropic stimulation with acetylstrophanthidin and the adenylate cyclase activator forskolin was preserved. After a minimally effective dose of forskolin was given to elevate intracellular cyclic AMP levels, the inotropic responses of muscles from the failing hearts to phosphodiesterase inhibitors were markedly potentiated. These data indicate that an abnormality in cyclic AMP production may be a fundamental defect present in patients with end-stage heart failure that can markedly diminish the effectiveness of agents that depend on generation of this nucleotide for production of a positive inotropic effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 920
Baim, D. S., McDowell, A. V., Cherniles, J., Monrad, E. S., Parker, J. A., Edelson, J., Braunwald, E., & Grossman, W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309293091302 · Cited by 337
Self-citationEpstein, F. H., Lefkowitz, R. J., Caron, M. G., & Stiles, G. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406143102406 · Cited by 335
Altered calcium handling in experimental pressure-overload hypertrophy in the ferret.
Gwathmey, J. K., & Morgan, J. P. (1985) · Circulation Research · doi:10.1161/01.res.57.6.836 · Cited by 227
Self-citationMechanism of action of therapeutic levels of cardiac glycosides
NOBLE, D. (1980) · Cardiovascular Research · doi:10.1093/cvr/14.9.495 · Cited by 181
Inotropic drugs and their mechanisms of action
Scholz, H. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80231-4 · Cited by 148
Pharmacology and inotropic potential of forskolin in the human heart.
Bristow, M. R., Ginsburg, R., Strosberg, A. D., Montgomery, W., & Minobe, W. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111404 · Cited by 135
Katz, A. M. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80387-8 · Cited by 125
Inotropic and electrophysiological effects of histamine on human ventricular heart muscle.
Eckel, L., Gristwood, R., Nawrath, H., Owen, D. A., & Satter, P. (1982) · Journal of Physiology · doi:10.1113/jphysiol.1982.sp014332 · Cited by 82
Lindenmayer, G. E., Sordahl, L. A., Harigaya, S., Allen, J. C., Besch, H. R., & Schwartz, A. (1971) · The American Journal of Cardiology · doi:10.1016/0002-9149(71)90303-1 · Cited by 71
Petein, M., Levine, T. B., & Cohn, J. N. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80227-2 · Cited by 39
Cited by
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Winslow, R. L., Rice, J., Jafri, S., Marbán, E., & O’Rourke, B. (1999) · Circulation Research · doi:10.1161/01.res.84.5.571 · Cited by 797
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
Cardiomyopathy of Overload: A Major Determinant of Prognosis in Congestive Heart Failure
Epstein, F. H., & Katz, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220206 · Cited by 564
Metadata
- Authors
- Feldman, M. D., Copelas, L., Gwathmey, J. K., Phillips, P., Warren, S. E., Schoen, F. J., Grossman, W., & Morgan, J. P.
- Venue
- Circulation
- Published
- 1987-02
- Volume
- 75
- Issue
- 2
- Pages
- 331-339
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2045202330
- Cited by
- 486
- References
- 12
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.